New combo therapy targets tough skin cancers
NCT ID NCT05085496
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests combining precise radiation (SBRT) with the immunotherapy drug atezolizumab for people with advanced skin squamous cell carcinoma that can or cannot be removed by surgery. The study aims to see if this combination is safe and helps control the cancer better than either treatment alone. About 12 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SKIN SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New combo therapy aims to shrink inoperable skin cancers
- Can a smaller dose of this cancer drug still work? new trial aims to find out
- Custom-Made cancer vaccine shows promise in advanced tumors
- Rare cancer hope: immune drug shows promise in phase 2 trial
- Experimental virus-antibody combo tested for tough skin cancers
- Immunotherapy before surgery shows promise for tough skin cancers